A 74-year-old woman with permanent atrial fibrillation, hypertension and prior ischaemic stroke presents for review. Her CHA₂DS₂-VASc score is 5. She is on metoprolol for rate control only. Renal function is normal and she has no significant bleeding history. What is the most appropriate management of her stroke risk?